CD8A and neoplasm: In addition, a tumor-induced reduction in the conventional dendritic cell 1 development limits the direct T-cell activation by cancer antigens, which mediates impaired antitumor CD8+ T-cell responses and leads to the loss of control of tumor progression (Figure 2) (120).